Nucor earnings beat by $0.08, revenue fell short of estimates
Robert L. Scavo, the Chief Information Officer of Alignment Healthcare, Inc. (NASDAQ:ALHC), recently executed a series of stock sales totaling approximately $184,906. The healthcare company, currently valued at $3.3 billion, has seen its stock surge over 250% in the past year, according to InvestingPro data. The transactions, which occurred on March 18 and March 19, involved the sale of 11,157 shares of common stock. The shares were sold at prices ranging from $16.088 to $16.9588 per share. These sales were made to cover tax obligations related to vested stock units and do not represent discretionary trades by Scavo. Following these transactions, Scavo retains ownership of 705,817 shares in the company. The stock currently trades near its 52-week high, with analyst price targets ranging from $9 to $21. For deeper insights into insider trading patterns and 12+ additional ProTips, visit InvestingPro.
In other recent news, Alignment Healthcare reported its fourth-quarter 2024 earnings, surpassing analysts’ expectations with an EPS of -0.16 compared to the forecast of -0.18. The company’s revenue also exceeded projections, reaching $701.2 million against the expected $674.97 million. Piper Sandler demonstrated confidence in the company’s future performance by increasing the price target to $21.00 from $14.00, maintaining an Overweight rating. Raymond (NSE:RYMD) James also raised its price target for Alignment Healthcare to $19.00, citing robust performance in the fourth quarter, where the company exceeded expectations in several key areas. Alignment Healthcare achieved its first year of adjusted EBITDA profitability, a significant milestone for the company. The company provided guidance for 2025, forecasting revenue between $3.72 billion and $3.78 billion, marking a 40% year-over-year growth at the midpoint. Membership growth was also notable, with an increase of approximately 59% in 2024. Analysts have highlighted the company’s ability to grow at a rate of 20% or more annually while enhancing EBITDA profitability.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.